Chimeric antigen receptor T cells for gamma-delta T cell malignancies

Leukemia. 2022 Feb;36(2):577-579. doi: 10.1038/s41375-021-01385-0. Epub 2021 Aug 13.

Authors

P A Wawrzyniecka¹, L Ibrahim¹, G Gritti², M A Pule¹, P M Maciocia³

Affiliations

¹ Department of Haematology, Cancer Institute, University College London, London, UK.
² Hematology Department, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII Hospital, Bergamo, Italy.
³ Department of Haematology, Cancer Institute, University College London, London, UK. p.maciocia@ucl.ac.uk.

No abstract available

MeSH terms

Animals
Immunotherapy, Adoptive / methods*
Leukemia, Experimental / immunology
Leukemia, Experimental / pathology
Leukemia, Experimental / therapy*
Mice
Receptors, Antigen, T-Cell, gamma-delta / immunology*
Receptors, Chimeric Antigen / immunology*
T-Lymphocytes / immunology*

Substances

Receptors, Antigen, T-Cell, gamma-delta
Receptors, Chimeric Antigen